NICE - Endorsed Clinical Guidelines 2017/2018

Topics:

It is important to note that the advice contained within the guidance does not override or replace the individual responsibility of health professionals to make appropriate decisions in the circumstances of their individual patients, in consultation with the patient and/or guardian or carer. This would, for example, include situations where individual patients have other conditions or complications that need to be taken into account in determining whether the NICE guidance is fully appropriate in their case. Clinical guidelines frequently make reference to specific legislation and guidance that do not apply in Northern Ireland. All clinical guidelines should be read taking these differences into consideration. The following NICE clinical guidelines have been endorsed during 2017/2018

Clinical Guidelines 

Fully Endorsed 

March 2018

National Institute for Health and Clinical Excellence (NICE) NG82 - Age-related macular degeneration - HSC (SQSD) (NICE NG82) 06/18

National Institute for Health and Clinical Excellence (NICE) NG83 -Oesophago-gastric cancer: assessment and management in adults  - HSC (SQSD) (NICE NG83) 07/18

January 2018

National Institute for Health and Clinical Excellence (NICE) NG80 - Asthma: diagnosis, monitoring and chronic asthma management - HSC (SQSD) (NICE NG80) 02/18

December 2017

National Institute for Health and Clinical Excellence (NICE) NG28 - Depression in children and young people: identification and management - HSC (SQSD) (NICE NG28) 39/17

  • This guidance has been updated and replaced by NICE Clinical Guideline NG134 - Depression in children and young people: identification and management, which was endorsed by the DoH in August 2019.

National Institute for Health and Clinical Excellence (NICE) NG78 - Cystic fibrosis: diagnosis and management - HSC (SQSD) (NICE NG78) 41/17

National Institute for Health and Clinical Excellence (NICE) NG77 - Cataracts in adults: management - HSC (SQSD) (NICE NG77) 42/17

National Institute for Health and Clinical Excellence (NICE) NG81 - Glaucoma: diagnosis and management - HSC (SQSD) (NICE NG81) 43/17

  • This guidance updates and replaces NICE Clinical Guideline CG85 endorsed by DoH in June 2010.

November 2017

National Institute for Health and Clinical Excellence (NICE) NG75 - Faltering growth: recognition and management of faltering growth in children - HSC (SQSD) (NICE NG75) 38/17

October 2017

National Institute for Health and Clinical Excellence (NICE) NG72 - Developmental follow-up of children and young people born preterm - HSC (SQSD) (NICE NG72) 33/17

National Institute for Health and Clinical Excellence (NICE) NG73 - Endometriosis: diagnosis and management - HSC (SQSD) (NICE NG73) 35/17

  • This guidance partially updates NICE Clinical Guideline CG156 - Fertility problems: assessment and treatment, which was endorsed by DOH in November 2013.

September 2017

National Institute for Health and Clinical Excellence (NICE) NG71 - Parkinson’s Disease in Adults - HSC (SQSD) (NICE NG71) 30/17

  • This guidance updates and replaces NICE Clinical Guideline CG35 endorsed by DoH in June 2007. 

July 2017

National Institute for Health and Clinical Excellence (NICE) NG69 - Eating Disorders: Recognition and Treatment - HSC (SQSD) (NICE NG69) 26/17

June 2017

National Institute for Health and Clinical Excellence (NICE) NG29 - Intravenous Fluid Therapy in Children and Young People in Hospital - HSC (SQSD) (NICE NG29) 24/17

May 2017

National Institute for Health and Clinical Excellence (NICE) NG66 - Mental Health of Adults in Contact with the Criminal Justice System - HSC (SQSD) (NICE NG66) 22/17

April 2017

National Institute for Health and Clinical Excellence (NICE) NG65 - Spondyloarthritis in Over 16s: Diagnosis and Management - HSC (SQSD) (NICE CG65) 17/17

Related articles

Back to top